Chimera Investment (CIM) → Stock, financial statements

Dividends

Summary • Financial statements • Analyst Recommendations

Favorites

CIM Ticker
🇺🇸 NYSE Exchange
38 Employees

💰 Financials Sector
• Industry
Matthew John Lambiase CEO

Website ➟ IR
SEC Filings

Website

SEC Filings

13 rated

comming soon

Financial statements — Chimera Investment

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.

	2020	2019	2018	2017	2016
Total Revenue	1B	1.4B	1.3B	1.1B	930M
Cost Of Revenue	180K	0	0	0	0
Gross Profit	1B	1.4B	1.3B	1.1B	930M
Research and Development	0	0	0	0	0
Selling General and Admin	25M	27M	24M	18M	18M
Operating Expense	1.3B	1.4B	950M	780M	600M
Operating Income	-280M	-26M	320M	360M	330M
Other Income Expense Net	370M	440M	91M	170M	130M
EBIT	89M	410M	410M	520M	460M
Interest Income	0	0	0	0	0
Pretax Income	89M	410M	410M	520M	550M
Income Tax	160K	190K	91K	110K	83K
Minority Interest	0	0	0	0	0
Net Income	15M	340M	370M	490M	550M
Net Income Basic	15M	340M	370M	490M	550M

	2020	2019	2018	2017	2016
Current cash	0	0	0	0	0
Short term investments	17B	26B	27B	21B	16B
Receivables	81M	560M	120M	100M	80M
Inventory	0	0	0	0	0
Other current assets	0	3.6M	37M	49M	9.7M
Current assets	17B	27B	27B	21B	17B
Long term investments	79M	190M	250M	110M	170M
Property plant equipment	0	0	0	0	0
Goodwill	0	0	0	0	0
Intangible assets	0	0	0	0	0
Other assets	79M	190M	250M	110M	170M
Total assets	18B	27B	28B	21B	17B
Accounts payable	0	0	0	0	0
Current long term debt	14B	22B	23B	17B	13B
Other current liabilities	230M	1.4B	1.4B	740M	690M
Total current liabilities	14B	23B	24B	18B	14B
Long term debt	0	0	0	0	0
Other liabilities	0	0	0	0	0
Minority Interest	0	0	0	0	0
Total Liabilities	14B	23B	24B	18B	14B
Common stock	210M	190M	190M	190M	190M
Retained earning	3.9B	3.8B	3.4B	3B	2.4B
Treasury stock	0	0	0	0	0
Capital surplus	•	•	•	•	•
Shareholder equity	3.8B	4B	3.7B	3.6B	3.1B
Net tangible assets	3.8B	4B	3.7B	3.6B	3.1B

	2020	2019	2018	2017	2016
Net Income	15M	340M	370M	490M	550M
Depreciation	0	0	0	0	0
Changes in receivables	-480M	440M	23M	21M	13M
Changes in inventories	0	0	0	0	0
Cash change	160M	62M	-16M	-110M	64M
Cash flow	260M	65M	300M	490M	550M
Capital expenditures	0	0	0	0	0
Investments	•	•	•	•	•
Investing activity other	•	•	•	•	•
Total investing cash flows	8.3B	1.2B	-6B	-4.3B	-1.3B
Dividends paid	•	•	•	•	•
Net borrowings	-3.6B	-4.5B	-4.6B	-4.1B	-3.4B
Other financing cash flows	•	•	•	•	•
Cash flow financing	-8.4B	-1.2B	5.7B	3.7B	780M
Exchange rate effect	•	•	•	•	•

Analyst Recommendations

This chart is a recommendation for investors. To provide forecasts, analysts and brokers use companies' public financial reports and speak with their employees and clients. The end result is a solution that's marked on the chart, which shows analysts' opinions at different periods of time. Move your cursor to track on what the dates the recommendations changed.

Investors shouldn't only follow analyst recommendations. Forecasts should be used to supplement existing strategies and plans. Trading based on a recommendation chart is is considered bad practice. Analyst reports should only be used in conjunction with your own analytics.

Sell

Also known as strong sell, it's a recommendation to sell a security or to liquidate an asset.

Underweight

A recommendation that means a stock is expected to do slightly worse than the overall stock market return. Underperform can also be expressed as "moderate sell", "weak hold" and "underweight."

Hold

A company with a hold recommendation is expected to perform on par with comparable companies or in line with the market.

Overweight

Also known as "moderate buy", "accumulate", and "overweight." Outperform is an analyst recommendation meaning a stock is expected to do slightly better than the market return.

Buy

Also known as strong buy and "on the recommended list." Needless to say, buy is a recommendation to purchase a specific security.

Also known as strong sell, it's a recommendation to sell a security or to liquidate an asset.

A recommendation that means a stock is expected to do slightly worse than the overall stock market return. Underperform can also be expressed as "moderate sell", "weak hold" and "underweight."

A company with a hold recommendation is expected to perform on par with comparable companies or in line with the market.

Also known as "moderate buy", "accumulate", and "overweight." Outperform is an analyst recommendation meaning a stock is expected to do slightly better than the market return.

Also known as strong buy and "on the recommended list." Needless to say, buy is a recommendation to purchase a specific security.

Chimera Investment Corp. operates as a real estate investment trust. It engages in investing directly or indirectly through its subsidiaries, on a leveraged basis, in a portfolio of mortgage assets. It includes residential mortgage loans, residential mortgage-backed securities, commercial mortgage loans, real estate-related securities, and various other asset classes. The company was founded on June 1, 2007 and is headquartered in New York, NY.

Related Companies

No data